NEUE PHENYLDERIVATE

European patent · EP3565806 · In force

Register entry

Publication number
EP3565806
Application number
EP18709129
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 5, 2018
Published
Nov 13, 2019
Granted
Mar 2, 2022
Protection ends at the latest
Jan 4, 2038
Next annual fee due
Jan 31, 2027
IPC classes
C07D 233/91 (2006.01)
A61P 3/04 (2006.01)
A61P 9/00 (2006.01)
A61P 3/10 (2006.01)
A61K 31/4168 (2006.01)
Priority
US 201762443244 P 06.01.2017
US 201762581355 P 03.11.2017
US 201762585326 P 13.11.2017
PCT application
PCT/US2018/012491 05.01.2018
PCT publication
WO2018/129258 12.07.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jan 11, 2023

    Change

    Published in Swissreg on 11.01.2023

  6. May 19, 2022

    Agent entered

    Representative
    Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich

    Published in Swissreg on 19.05.2022

  7. Mar 2, 2022

    Granted

    Published in Swissreg on 02.03.2022

Parties

Holder

Rivus Pharmaceuticals, Inc.

706B Forest Street, Charlottesville, VA 22903, US

Agent

Schmauder & Partner AG

Schmauder & Partner AG Patent- und Markenanwälte VSP

Zwängiweg 7, 8038 Zürich

Inventor

KHAN, Shaharyar M.

Charlottesville, VA 22901, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.